Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis

被引:87
作者
Huang, Ling C.
Reins, Rose Y.
Gallo, Richard L.
McDermott, Alison M.
机构
[1] Univ Houston, Coll Optometry, Houston, TX 77204 USA
[2] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
关键词
D O I
10.1167/iovs.07-0274
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To examine the clinical progression and innate immune responses during Pseudomonas aeruginosa (PA) keratitis in cathelicidin-deficient (KO) mice. METHODS. PA (ATCC 19660) keratitis was induced in KO mice and wild-type (WT) littermates generated on a 129/SVJ background. Clinical score and histopathology were used to monitor the progression of infection at postinfection (PI) days 1, 3, 7, 14, and 21. Mouse corneas were harvested for viable bacteria quantitation, and myeloperoxidase (MPO) assays were performed to determine the number of infiltrating neutrophils. ELISA was used to quantitate interleukin (IL)-1 beta, IL- 6, macrophage inflammatory peptide (MIP)-2, keratinocyte-derived chemokine ( KC), tumor necrosis factor (TNF)-alpha, and vascular endothelial growth factor (VEGF) levels in the corneas. RESULTS. WT mice were resistant (cornea healed), whereas KO mice showed increased susceptibility (corneas failed to recover by 21 days or perforated) to PA infection. Clinical scores were significantly elevated in the infected corneas of KO mice versus WT mice at 7, 14, and 21 days PI. Absence of cathelicidin resulted in significantly delayed clearance of PA in the cornea and an increased number of infiltrating neutrophils at 1, 3, 7, and 14 days PI. KO mice also exhibited differential expression of protein levels for IL- 1 beta, IL-6, MIP-2, KC, TNF-alpha, and VEGF up to day 21 PI compared with the WT mice. CONCLUSIONS. Cathelicidin-deficient mice showed considerable susceptibility to PA keratitis. The present study demonstrates direct in vivo evidence that endogenous expression of cathelicidin provides defense against corneal PA infection indicating its importance in host innate immunity at the ocular surface.
引用
收藏
页码:4498 / 4508
页数:11
相关论文
共 80 条
[51]   INTERLEUKIN-8 AS A MACROPHAGE-DERIVED MEDIATOR OF ANGIOGENESIS [J].
KOCH, AE ;
POLVERINI, PJ ;
KUNKEL, SL ;
HARLOW, LA ;
DIPIETRO, LA ;
ELNER, VM ;
ELNER, SG ;
STRIETER, RM .
SCIENCE, 1992, 258 (5089) :1798-1801
[52]   An angiogenic role for the human peptide antibiotic LL-37/hCAP-18 [J].
Koczulla, R ;
von Degenfeld, G ;
Kupatt, C ;
Krötz, F ;
Zahler, S ;
Gloe, T ;
Issbrüicker, K ;
Unterberger, P ;
Zaiou, M ;
Lebherz, C ;
Karl, A ;
Raake, P ;
Pfosser, A ;
Boekstegers, P ;
Welsch, U ;
Hiemstra, PS ;
Vogelmeier, C ;
Gallo, RL ;
Clauss, M ;
Bals, R .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (11) :1665-1672
[53]   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant [J].
Kurosaka, K ;
Chen, Q ;
Yarovinsky, F ;
Oppenheim, JJ ;
Yang, D .
JOURNAL OF IMMUNOLOGY, 2005, 174 (10) :6257-6265
[54]  
LEE J, 1995, J IMMUNOL, V155, P2158
[55]   Role of cytokines and chemokines in pseudomonal keratitis [J].
Matsumoto, K ;
Ikema, K ;
Tanihara, H .
CORNEA, 2005, 24 (08) :S43-S49
[56]   Defensin expression by the cornea:: Multiple signalling pathways mediate IL-1β stimulation of hBD-2 expression by human corneal epithelial cells [J].
McDermott, AM ;
Redfern, RL ;
Zhang, B ;
Pei, Y ;
Huang, L ;
Proske, RJ .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (05) :1859-1865
[57]   Human β-defensin 2 is up-regulated during re-epithelialization of the cornea [J].
McDermott, AM ;
Redfern, RL ;
Zhang, B .
CURRENT EYE RESEARCH, 2001, 22 (01) :64-67
[58]  
Mela Ephigenia K, 2003, Eye Contact Lens, V29, P207
[59]   Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva [J].
Murakami, M ;
Ohtake, T ;
Dorschner, RA ;
Gallo, RL .
JOURNAL OF DENTAL RESEARCH, 2002, 81 (12) :845-850
[60]   Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues [J].
Nagaoka, I ;
Hirota, S ;
Niyonsaba, F ;
Hirata, M ;
Adachi, Y ;
Tamura, H ;
Tanaka, S ;
Heumann, D .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (05) :972-982